Abstract | AIM: The aim of this case report was to show the importance to research metabolic etiology, especially a carnitine deficiency in dilated cardiomyopathy of children. CASE REPORT: A three years old Togolese child presented muscular hypotonia, dyspnea. Examination showed left galop murmur and systolic murmur 2/6. Chest X-ray showed cardiomegaly (CTI: 0.66), electrocardiogram, a sinusal rythm, left ventricle hypertrophy and T wave abnormalities. Echocardiogram showed a markedly dilated left ventricle with reduced systolic function (EF: 0.43; reference range 0.55-0.80) and moderate mitral regurgitation. The inflammatory signs where negatives. Magnetic resonance imaging don't show signs of ischemic or myocarditis. The levels of free and total plasmatic carnitine decreased: 3μmol/L (N: 18-48μmol/L) and 5μmol/l (N: 29-70μmol/L) respectively. Mutation analysis of the gene SLC22A5 confirms the diagnosis of primary systemic carnitine deficiency. Treatment with oral carnitine was started at 200mg/kg per day. Within three weeks of treatment, we observed the decrease of all symptoms and the left ventricular size and function normalized (EF: 0.62). He has now been on oral carnitine for live. CONCLUSION:
|
Authors | S Baragou, M Pio, S Di Bernardo, T Boulos Ksontini, S Jiekak Dommange, L Bonafe, E Meijboom, N Sekarski |
Journal | Annales de cardiologie et d'angeiologie
(Ann Cardiol Angeiol (Paris))
Vol. 63
Issue 2
Pg. 107-10
(Apr 2014)
ISSN: 1768-3181 [Electronic] France |
Vernacular Title | Une cause de cardiomyopathie dilatée chez l'enfant: le déficit primaire en carnitine. |
PMID | 22260907
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2011 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Biomarkers
- Organic Cation Transport Proteins
- SLC22A5 protein, human
- Solute Carrier Family 22 Member 5
- Vitamin B Complex
- Carnitine
|
Topics |
- Biomarkers
(blood)
- Cardiomyopathies
(complications, diagnosis, drug therapy, genetics)
- Cardiomyopathy, Dilated
(diagnosis, drug therapy, etiology, genetics)
- Carnitine
(administration & dosage, deficiency, genetics, therapeutic use)
- Child, Preschool
- Dyspnea
(etiology)
- Humans
- Hyperammonemia
(complications, diagnosis, drug therapy, genetics)
- Male
- Muscular Diseases
(complications, diagnosis, drug therapy, genetics)
- Mutation
- Organic Cation Transport Proteins
(genetics)
- Prognosis
- Solute Carrier Family 22 Member 5
- Time Factors
- Treatment Outcome
- Vitamin B Complex
(administration & dosage, therapeutic use)
|